Eric Bironneau

Eric Bironneau

Chief Business Officer

Executive Leader Business Development
About

Eric Bironneau brings over two decades of commercial leadership experience to the company, including serving as Vice President, Global Sales & Business Development at Axplora and Novasep.

As Chief Business Officer, Eric has responsibility for Quotient Sciences’ commercial organization including drug product, clinical, Translational Pharmaceutics® and commercial lines, as well as for Quotient Sciences’ strategic partnerships.

Quotient Sciences Translational Pharmaceutics
Translational Pharmaceutics, Drug Product Optimization, First-in-Human, Human ADME

Translational Pharmaceutics® Integrated Drug Development Info Sheet

10 March 2025 Read More

Latest news from Quotient Sciences

More News
News & Announcements, Nottingham, UK, Artificial Intelligence, Translational Pharmaceutics®, Formulation Development Quotient Sciences and Acesion Pharma Announce Collaboration on AI-Enhanced Formulation Development to Advance Atrial Fibrillation Pipeline By: Dr. Andrew Lewis
Read More
News & Announcements, Artificial Intelligence, Translational Pharmaceutics®, Formulation Development Quotient Sciences shortlisted for "Best Use of AI in Clinical Development & Trial Innovation" at the Scrip Awards 2026 By: Dr. Andrew Lewis
Read More